Features of antihypertensive therapy in the Russian population: data from the ESSE-RF3 study
Aim. To evaluate the usage of antihypertensive drugs (AHDs) and their combinations in participants aged 35 to74 years with arterial hypertension (AH) in the population-based study ESSE-RF3.Material and methods. Representative samples of the population aged 35 to 74 years from 15 regions of Russia (n...
Saved in:
Similar Items
-
Combined Therapy of Arterial Hypertension. The Opinion of a Clinical Pharmacologist
by: M. V. Zhuravleva, et al.
Published: (2020-09-01) -
Prevalence, awareness, treatment and control of arterial hypertension depending on regional characteristics in Russia: results of the ESSE-RF study 2012-2022 — evidence of COVID-19 impact?
by: S. A. Maksimov, et al.
Published: (2025-06-01) -
ANALYSIS OF THE PRACTICE OF COMBINATIONAL ANTIHYPERTENSION THERAPY BY THE DATA FROM TWO OUTPATIENT REGISTRIES
by: S. Yu. Martsevich, et al.
Published: (2017-10-01) -
Bioequivalence study of fixed-dose combination Losartan + amlodipine + rosuvastatin Sanofi in comparison with coadministered fixed- dose combination Lozap® AM and monocomponent drug Crestor® in healthy subjects
by: A. L. Khokhlov, et al.
Published: (2022-05-01) -
RESULTS OF OUTPATIENT PROGRAM ON EFFECTIVE THERAPY OF REFRACTORY ARTERIAL HYPERTENSION
by: M. M. Batyushin, et al.
Published: (2015-12-01)